Individuals of all ages using AID systems may treat non-severe hypoglycemia events with less fast-acting carbohydrate (i.e
The generic formulation makes it one of the least expensive branded-mechanism anti-obesity drugs available
Patients should contact their GP or prescribing clinician if they experience: Severe or persistent cramps that do not respond to simple measures or significantly impact daily activities and sleep quality Frequent cramping occurring multiple times daily or nightly Associated symptoms such as muscle weakness, numbness, tingling, or changes in sensation, which may indicate neurological involvement Visible muscle changes including swelling, redness, tenderness, or asymmetry between legs Signs of dehydration such as dizziness, reduced urine output, dark urine, or confusion These features may indicate underlying conditions requiring investigation, such as significant electrolyte disturbances, peripheral neuropathy (particularly relevant in diabetes), peripheral arterial disease, or, rarely, more serious muscle disorders
As new red blood cells form rapidly, potassium may move from the bloodstream into these cells
Yes, modest heart rate increases of 2-4 beats per minute are documented in clinical trials and noted in the FDA prescribing information
For instance, while GLP-1 agonists are primarily metabolised by the kidneys and have a low potential for significant drug-drug interactions, it is still important to monitor patients closely when combining therapies
)
